Search

everythinglearnresearchcommunity

for

Search:↓

Erlotinib can cause hair loss as a side effect.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Erlotinib can cause unexpected side effects like eyelash growth and scarring.

Metabolic syndrome may increase the risk of small cell lung cancer.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Malignant melanoma is the deadliest skin cancer, while BCC is the most common but rarely spreads, and SCC is more aggressive than BCC.

A 70-year-old man with skin cancer on both sides of his forehead was treated with surgery and cryotherapy, highlighting the need for early detection and prevention.

Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

An elderly woman's upper lip lump, thought to be a mucocele, was actually a rare type of lymphoma usually found on legs, treated successfully with chemotherapy and radiation.

Dr. Connelly agrees that linear basal cell carcinomas might be more aggressive but highlights the study's lack of clear criteria to identify them.

A rare case showed basal cell carcinoma and leiomyosarcoma coexisting, needing careful diagnosis and treatment.

Researchers found that hair follicle stem cells can become squamous cell carcinoma due to Ras activation, which could lead to new treatments.

Patients with cutaneous lupus erythematosus have a higher risk of skin cancer and other cancers.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

Clouston syndrome can lead to skin cancer, so monitoring is crucial.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Skin cancer in sun-exposed areas is more likely to come back.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.